API-1

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameAPI-1
Drug Alias NameAPI-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidy-1-prolyl isomerase inhibitors
TargetsPeptidy-1-prolyl isomerase
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesSichuan University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A